Castronovo V - Search Results

1

Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration.

Costanza B, Rademaker G, Tiamiou A, De Tullio P, Leenders J, Blomme A, Bellier J, Bianchi E, Turtoi A, Delvenne P, Bellahcène A, Peulen O, Castronovo V. Costanza B, et al. Among authors: castronovo v. Int J Cancer. 2019 Sep 15;145(6):1570-1584. doi: 10.1002/ijc.32247. Epub 2019 Mar 28. Int J Cancer. 2019. PMID: 30834519 Free article.

2

Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues.

Waltregny D, De Leval L, Glénisson W, Ly Tran S, North BJ, Bellahcène A, Weidle U, Verdin E, Castronovo V. Waltregny D, et al. Among authors: castronovo v. Am J Pathol. 2004 Aug;165(2):553-64. doi: 10.1016/S0002-9440(10)63320-2. Am J Pathol. 2004. PMID: 15277229 Free PMC article.

3

Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition.

Chaplet M, Detry C, Deroanne C, Fisher LW, Castronovo V, Bellahcéne A. Chaplet M, et al. Among authors: castronovo v. Biochem J. 2004 Dec 15;384(Pt 3):591-8. doi: 10.1042/BJ20040380. Biochem J. 2004. PMID: 15324309 Free PMC article.

4

Galectin-3 and cancer (Review).

Califice S, Castronovo V, Van Den Brûle F. Califice S, et al. Among authors: castronovo v. Int J Oncol. 2004 Oct;25(4):983-92. Int J Oncol. 2004. PMID: 15375548 Review.

5

Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness.

Chaplet M, Waltregny D, Detry C, Fisher LW, Castronovo V, Bellahcène A. Chaplet M, et al. Among authors: castronovo v. Int J Cancer. 2006 Feb 15;118(4):850-6. doi: 10.1002/ijc.21442. Int J Cancer. 2006. PMID: 16108038 Free article.

6

Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents.

de Leval X, Dassesse T, Dogné JM, Waltregny D, Bellahcène A, Benoit V, Pirotte B, Castronovo V. de Leval X, et al. Among authors: castronovo v. J Pharmacol Exp Ther. 2006 Sep;318(3):1057-67. doi: 10.1124/jpet.106.101188. Epub 2006 May 23. J Pharmacol Exp Ther. 2006. PMID: 16720756

7

A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden.

Le Gall C, Bellahcène A, Bonnelye E, Gasser JA, Castronovo V, Green J, Zimmermann J, Clézardin P. Le Gall C, et al. Among authors: castronovo v. Cancer Res. 2007 Oct 15;67(20):9894-902. doi: 10.1158/0008-5472.CAN-06-3940. Cancer Res. 2007. PMID: 17942921

8

Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis.

Mottet D, Bellahcène A, Pirotte S, Waltregny D, Deroanne C, Lamour V, Lidereau R, Castronovo V. Mottet D, et al. Among authors: castronovo v. Circ Res. 2007 Dec 7;101(12):1237-46. doi: 10.1161/CIRCRESAHA.107.149377. Epub 2007 Oct 18. Circ Res. 2007. PMID: 17947801

9

Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression.

Lamour V, Detry C, Sanchez C, Henrotin Y, Castronovo V, Bellahcène A. Lamour V, et al. Among authors: castronovo v. J Biol Chem. 2007 Dec 14;282(50):36240-9. doi: 10.1074/jbc.M705833200. Epub 2007 Oct 22. J Biol Chem. 2007. PMID: 17956871 Free article.

10

Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.

Saidi A, Javerzat S, Bellahcène A, De Vos J, Bello L, Castronovo V, Deprez M, Loiseau H, Bikfalvi A, Hagedorn M. Saidi A, et al. Among authors: castronovo v. Int J Cancer. 2008 May 15;122(10):2187-98. doi: 10.1002/ijc.23313. Int J Cancer. 2008. PMID: 18092325 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

301 results

Search Page